P44. Activin A is novel circulating biomarker in lung cancer

BACKGROUND: Therapeutic decision making for the treatment of lung cancer is often a complex and challenging task. Biomarkers are urgently needed that can facilitate the early detection of these malignant diseases and can predict which therapeutic modality can significantly contribute to tumor contro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transl Lung Cancer Res
Autores principales: Rozsas, Anita, Hoda, Mir Alireza, Klikovits, Thomas, Schlech, Karin, Laszlo, Viktoria, Grusch, Michael, Berger, Walter, Klepetko, Walter, Hegedus, Balazs, Dome, Balazs
Formato: Artigo
Lenguaje:Inglês
Publicado: Pioneer Bioscience Publishing Company 2014
Materias:
CELCC 2014 Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367750/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB056
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares